We are live on ! Find out more
BTEC

Principal Exchange-Traded Funds Principal Healthcare Innovators ETF

Delisted

BTEC was delisted on the 31st of July, 2024.

33 hedge funds and large institutions have $112M invested in Principal Exchange-Traded Funds Principal Healthcare Innovators ETF in 2021 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 16 increasing their positions, 4 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 4

50% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 4

3% more funds holding

Funds holding: 3233 (+1)

4% more capital invested

Capital invested by funds: $107M → $112M (+$4.24M)

Holders
33
Holders Change
+1
Holders Change %
+3.13%
% of All Funds
0.57%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
16
Reduced
4
Closed
4
Calls
Puts
Net Calls
Net Calls Change

BTEC Hedge Fund Activity: Q2 2021 in Review

33 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Principal Exchange-Traded Funds Principal Healthcare Innovators ETF (BTEC) for Q2 2021, worth a combined $112M — up 3.9% from $107M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new BTEC positions and 4 closed out — a net gain of 2 holders — while 16 added to existing stakes and 4 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $2.04M. The largest seller was Raymond James & Associates, cutting an estimated $2.87M.

  • 33 institutional investors held Principal Exchange-Traded Funds Principal Healthcare Innovators ETF (BTEC) as of Q2 2021, up from 32 in Q1 2021.
  • Funds reported $112M of Principal Exchange-Traded Funds Principal Healthcare Innovators ETF stock for Q2 2021, up 3.9% quarter-over-quarter.
  • 6 funds opened new Principal Exchange-Traded Funds Principal Healthcare Innovators ETF positions in Q2 2021 and 4 closed out, a net change of +2 holders.
  • The largest Principal Exchange-Traded Funds Principal Healthcare Innovators ETF buyer in Q2 2021 was Morgan Stanley, an estimated $2.04M added.
  • The largest Principal Exchange-Traded Funds Principal Healthcare Innovators ETF seller in Q2 2021 was Raymond James & Associates, an estimated $2.87M sold.

Based on aggregated 13F filings for Q2 2021.